My Authors
Read all threads
There's been a lot of focus on—and confusion about—the potential of hydroxychloroquine in the #COVID19 pandemic.
There is emerging data on the drug's efficacy. The first large observational study published in @NEJM on May 7 found no evidence the drug helps. Other studies, including a May 11 study in @JAMA, have replicated that finding and raised questions about safety in sick patients.
Though these are important studies and I'm glad they’ve been published, I'd like to see more rigorous studies on hydroxychloroquine from randomized, controlled trials.
One major potential limitation of observational studies involves "residual confounding"—despite efforts to correct for baseline differences, it’s possible sicker patients were more likely to get the medication, which could make it appear ineffective even if it is helpful.
Given the limitations of these studies, there is no definitive evidence you're more likely to die if you get hydroxychloroquine but I do think it makes it unlikely that it will be a dramatically effective treatment, as I told @greta. bit.ly/2XVRjuC
Another new study was published yesterday in @NEJM of 821 people exposed to the virus who were randomized to hydroxychloroquine or a placebo. nyti.ms/2AFu5Rm
Unlike the observational studies, it was randomized and double-blinded. It didn't show that hydroxychloroquine had a measurable effect in preventing symptomatic infection compared to placebo.
The NEJM study also has important limitations. Lack of testing capacity means that most patients with symptoms weren’t tested, and there was no way to see if the medication could reduce the rate of asymptomatic infection.
But the results suggest that hydroxychloroquine is unlikely to be dramatically effective when given as post-exposure prophylaxis.
No study published to date has looked at the possibility that hydroxychloroquine taken before exposure could reduce the risk of infection or of serious illness. That’s why it’s so important that rigorous, well-designed, controlled trials get done.
The @WHO has resumed trials of hydroxychloroquine. We still have more to learn. Doctors and scientists continue to make discoveries about #COVID19 every day—and explore new ways to prevent and treat it.
Missing some Tweet in this thread? You can try to force a refresh.

Keep Current with Dr. Tom Frieden

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!